| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.55▼ | 3.55▼ | 3.55▼ | 3.60▼ | 3.41▲ |
| MA10 | 3.59▼ | 3.59▼ | 3.59▼ | 3.55▼ | 3.09▲ |
| MA20 | 3.61▼ | 3.61▼ | 3.60▼ | 3.41▲ | 2.94▲ |
| MA50 | 3.61▼ | 3.53▲ | 3.52▲ | 3.01▲ | 3.17▲ |
| MA100 | 3.53▼ | 3.48▲ | 3.38▲ | 2.93▲ | 4.26▼ |
| MA200 | 3.46▲ | 3.23▲ | 3.10▲ | 3.11▲ | 51.43▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.017▼ | -0.020▼ | -0.019▼ | -0.004▼ | 0.127▲ |
| RSI | 42.399▼ | 45.892▼ | 47.900▼ | 57.218▲ | 59.859▲ |
| STOCH | 14.198▼ | 13.773▼ | 13.773▼ | 79.901 | 68.682 |
| WILL %R | -72.917 | -72.917 | -72.917 | -22.996▲ | -24.540▲ |
| CCI | -107.637▼ | -111.817▼ | -114.538▼ | 20.359 | 119.056▲ |
|
Monday, June 16, 2025 04:30 PM
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, ...
|
|
Monday, June 16, 2025 04:20 PM
PETACH TIKVA, Israel, June 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today ...
|
|
Monday, June 16, 2025 04:20 PM
The Company Anticipates that with this Additional Funding, PolyPid’s Runway would be Extended beyond Anticipated U.S. Food and Drug Administration (“FDA”) Approval of D-PLEX₁₀₀.The Company Recently ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/06/25 | 3.58 | 3.58 | 3.465 | 3.53 | 88,564 |
| 27/06/25 | 3.61 | 3.61 | 3.55 | 3.57 | 104,800 |
| 26/06/25 | 3.59 | 3.70 | 3.55 | 3.58 | 110,100 |
| 25/06/25 | 3.63 | 3.74 | 3.55 | 3.74 | 224,300 |
| 24/06/25 | 3.74 | 3.748 | 3.55 | 3.58 | 337,200 |
| 23/06/25 | 3.46 | 3.68 | 3.40 | 3.68 | 563,300 |
| 20/06/25 | 3.26 | 3.32 | 3.12 | 3.28 | 212,600 |
| 18/06/25 | 3.52 | 3.54 | 3.26 | 3.31 | 339,617 |
| 17/06/25 | 3.57 | 3.645 | 3.48 | 3.53 | 593,887 |
| 16/06/25 | 3.45 | 3.705 | 3.33 | 3.67 | 303,812 |
|
|
||||
|
|
||||
|
|